缩写名/全名 |
NEUROPSYCHOPHARMACOL
NEUROPSYCHOPHARMACOLOGY |
||||||||||||||||||||
ISSN号 | 0893-133X | ||||||||||||||||||||
研究方向 | 医学-精神病学 | ||||||||||||||||||||
影响因子 | 2015:6.399, 2016:6.403, 2017:6.544, 2018:7.16, 2019:6.751, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 235 | ||||||||||||||||||||
出版年份 | 1987 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均2月 |
||||||||||||||||||||
录用比例 | 约28.75% | ||||||||||||||||||||
投稿链接 | http://mts-npp.nature.com/cgi-bin/main.plex | ||||||||||||||||||||
投稿官网 | http://www.nature.com/npp/index.html | ||||||||||||||||||||
h-index | 204 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0893-133X%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Opiate-associated contextual memory formation and retrieval are differentially modulated by dopamine D1 and D2 signaling in hippocampal-prefrontal connectivity. Author: Wang Y1, Zhang H2, Cui J1, Zhang J1, Yin F1, Guo H1, Lai J1, Xing B3,4. Journal: Neuropsychopharmacology. 2019 Jan;44(2):334-343. doi: 10.1038/s41386-018-0068-y. Epub 2018 Apr 17. PubMed DOI |
2. | A transdiagnostic neuroanatomical signature of psychiatric illness. Author: Gong Q1,2,3, Scarpazza C4,5, Dai J6, He M6, Xu X7, Shi Y7, Zhou B8, Vieira S4, McCrory E5, Ai Y8, Yang C8, Zhang F8, Lui S8, Mechelli A4. Journal: Neuropsychopharmacology. 2019 Apr;44(5):869-875. doi: 10.1038/s41386-018-0175-9. Epub 2018 Aug 8. PubMed DOI |
3. | Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia. Author: Takeuchi H1,2, Siu C3, Remington G2,4,5,6, Fervaha G2,7, Zipursky RB2,4, Foussias G2,4,5,6, Agid O8,9,10. Journal: Neuropsychopharmacology. 2019 May;44(6):1036-1042. doi: 10.1038/s41386-018-0278-3. Epub 2018 Nov 22. PubMed DOI |
4. | VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine. Author: Jiang C1, Lin WJ1,2,3, Labonté B1,4, Tamminga CA5, Turecki G6, Nestler EJ1,7, Russo SJ1,7, Salton SR8,9,10. Journal: Neuropsychopharmacology. 2019 Apr;44(5):971-981. doi: 10.1038/s41386-018-0277-4. Epub 2018 Nov 20. PubMed DOI |
5. | Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Author: Wilkinson ST1, Farmer C2, Ballard ED2, Mathew SJ3,4, Grunebaum MF5, Murrough JW6, Sos P7, Wang G8, Gueorguieva R9,10, Zarate CA Jr2. Journal: Neuropsychopharmacology. 2019 Jun;44(7):1233-1238. doi: 10.1038/s41386-019-0317-8. Epub 2019 Jan 17. PubMed DOI |
6. | Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder. Author: Li H1,2, Chang H1, Song X3, Liu W1,2, Li L1, Wang L1, Yang Y4,5, Zhang L4,5, Li W4,5, Zhang Y4,5, Zhou DS6, Li X6, Zhang C7, Fang Y7, Sun Y8,9, Dai JP8,9, Luo XJ1,2,10, Yao YG1,2,11, Xiao X12, Lv L13,14,15, Li M16,17,18. Journal: Neuropsychopharmacology. 2019 Feb 16. doi: 10.1038/s41386-019-0346-3. [Epub ahead of print] PubMed DOI |
7. | Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder. Author: Zhong J1, Li S2,3, Zeng W4, Li X2,3, Gu C1, Liu J2, Luo XJ5,6,7,8. Journal: Neuropsychopharmacology. 2019 Feb 16. doi: 10.1038/s41386-019-0345-4. [Epub ahead of print] PubMed DOI |
8. | Correction: Striato-cortical tracts predict 12-h abstinence-induced lapse in smokers. Author: Yuan K1,2,3,4,5, Zhao M6,7, Yu D8, Manza P9, Volkow ND9,10, Wang GJ9, Tian J6,7,11. Journal: Neuropsychopharmacology. 2019 Jun;44(7):1338. doi: 10.1038/s41386-019-0330-y. PubMed DOI |
9. | Correction: EphB2 in the medial prefrontal cortex regulates vulnerability to stress. Author: Zhang RX1,2,3, Han Y1,2,3, Chen C1, Xu LZ2,3, Li JL2, Chen N2, Sun CY1,2, Chen WH1, Zhu WL2, Shi J2, Lu L4,5,6. Journal: Neuropsychopharmacology. 2019 Jun;44(7):1339-1343. doi: 10.1038/s41386-019-0364-1. PubMed DOI |
10. | Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels. Author: Deng QS, Dong XY, Wu H, Wang W, Wang ZT, Zhu JW, Liu CF, Jia WQ, Zhang Y, Schachner M, Ma QH, Xu RX. Journal: Neuropsychopharmacology. 2016 Jan;41(2):440-53. doi: 10.1038/npp.2015.164. Epub 2015 Jun 11. PubMed |
|
|